MedPath
FDA Product

FERRIPROX

Product approved by U.S. Food and Drug Administration (US)

Basic Information

FERRIPROX

10122-103

Regulatory Information

10122-103

NDA021825

C73594

July 27, 2023

USA

These highlights do not include all the information needed to use FERRIPROX Tablets safely and effectively. See full prescribing information for FERRIPROX Tablets . FERRIPROX (deferiprone) tablets , for oral use Initial U.S. Approval: 2011

HUMAN PRESCRIPTION DRUG LABEL

11

Company Information

Chiesi USA, Inc.

088084228

Active Ingredients

DEFERIPRONE

Quantity: 1000 mg in 1 1

Code: 2BTY8KH53L

Class Code: ACTIB

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

METHYLCELLULOSE (15 MPA.S)

Code: NPU9M2E6L8

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

HYPROMELLOSE 2910 (5 MPA.S)

Code: R75537T0T4

Class Code: IACT

CROSPOVIDONE (120 .MU.M)

Code: 68401960MK

Class Code: IACT

POLYETHYLENE GLYCOL 8000

Code: Q662QK8M3B

Class Code: IACT

HYDROXYPROPYL CELLULOSE (1600000 WAMW)

Code: RFW2ET671P

Class Code: IACT

Active Moieties

DEFERIPRONE

Code: 2BTY8KH53L

© Copyright 2025. All Rights Reserved by MedPath